Results 251 to 260 of about 7,583,170 (338)
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Specificity and sensitivity of the fixed-point test for binary mixture distributions. [PDF]
Couto J, Lebreton M, van Maanen L.
europepmc +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
Fixed point results in intuitionistic fuzzy pentagonal controlled metric spaces with applications to dynamic market equilibrium and satellite web coupling. [PDF]
Ishtiaq U+3 more
europepmc +1 more source
Nilpotence of the commutator subgroup in groups admitting fixed point free operator groups [PDF]
Ernest E. Shult
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Fixed-point algorithms for solving the critical value and upper tail quantile of Kuiper's statistics. [PDF]
Zhang HY, Sun W, Chen X, Lin RJ, Zhou Y.
europepmc +1 more source